Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Chang KH, PhD, Zal T, PhD, MSc, Basyal M, BSc, Ostermann L, Muftuoglu M, MD, Mak PY, Jia Y, Tao W, Zal MA, MSc, Fogler WE, PhD, Magnani JL, PhD, Zhang W, MD, PhD, Carter BZ, PhD, Andreeff M , MD, PhD
How GLP-1 treatment and hormone replacement therapy (HRT) support each other Jacqueline Raposo Dr
Over 75% of health plans and over 50% of employers are moderately or very concerned about off-label use of GLP-1s approved for type 2 diabetes, but awareness of how much current spend is off-label is notably lower: nearly half of employers and a quarter of health plans are unsure
Analysts from William Blair highlighted concerns that the flexible dosing regimen may signal a challenging tolerability profile
Works cited The Unbundling of the Apothecary: How Vertically Integrated Telehealth Is Dismantling the Pharmaceutical Value Chain DrugPatentWatch Transform Data into Market Domination, accessed February 8, 2026, The Great Convergence: Pharmaceuticals, Digital Health, and the Direct-to-Patient Paradigm DrugPatentWatch Transform Data into Market Domination, accessed February 8, 2026, Hims & Hers Health, Inc
Beauty report: Perricone MD Essential FX Acyl-Glutathione Rejuvenating Moisturiser Words by Rachel Krasky Stay hydrated
